HPV Vaccination drive: India crosses 80 lakh milestone under nationwide campaign
New Delhi: India has administered over 80 lakh human papillomavirus (HPV) vaccinations under its nationwide campaign, marking another important milestone in strengthening preventive healthcare and protection against HPV infection and associated cancers, the Union health ministry said on Friday.
The nationwide HPV vaccination campaign was launched on February 28 to vaccinate girls aged 14 years. The HPV vaccine plays a vital role in preventing cervical cancer, one of the most common cancers affecting women, the ministry said.
Under the programme, the single-dose Gardasil-4 vaccine is being administered free of cost at government health facilities, including Ayushman Arogya Mandirs -- primary health centres (PHCs), community health centres (CHCs), sub-district and district hospitals and government medical colleges.
Also Read:HPV vaccination drive focused on voluntary participation, parental consent: JP Nadda
Vaccinations are administered in the presence of medical officers, while vaccination sites are linked to 24x7 adverse events following immunisation (AEFI) management centres for prompt management of any adverse events, it said.
According to the PTI report, parental consent is mandatory, and beneficiaries can register on the U-WIN platform. Vaccination is voluntary, and medical officers are trained to manage adverse events, according to the ministry.
Several states, including Madhya Pradesh, Andhra Pradesh, Tamil Nadu, Gujarat, Odisha, and Mizoram, are leading the nationwide campaign, the ministry added.
Health authorities are coordinating with schools, local bodies, and healthcare workers to ensure smooth access to the vaccine. Parents and guardians have been urged to support and encourage eligible girls to get vaccinated, it said.
The operational guidelines for the rollout of the HPV vaccination campaign have been disseminated to all states and Union Territories.
Medical Dialogues had earlier reported that the Delhi High Court on Wednesday refused to stay the Centre's ongoing Human Papillomavirus (HPV) vaccination campaign, observing that the petition failed to establish sufficient grounds to suspend the programme at this stage. However, the court emphasised that all regulatory and safety procedures must be followed before the vaccine is administered and sought responses from the Centre, the Central Drugs Standard Control Organisation (CDSCO) and the Indian Council of Medical Research (ICMR).
Also Read:AIIMS Delhi Director calls for nationwide support for HPV vaccination drive
